Lilly links COVID-19 antibody to a reduce hospitalization rate Eli Lilly has linked its anti-SARS-CoV-2 antibody to a lower rate of hospitalization in patients lately diagnosed with mild to moderate cases of COVID-19. Nevertheless, two of the three doses, including the highest studied in the phase 2 trial, flunk...Find More
The novel coronavirus since its outbreak in China November last year has now spread internationally. As per the latest updates, the Coronavirus (CoVID-19) has spread across 159 countries, with the death toll of 7,529 and confirmed cases reaching to 184,975 as on March 18. Several health organizations such as the WH...Find More
What is a Coronavirus? Coronavirus are a large group of viruses that are known for causing respiratory infections or diseases ranging from as normal as the common cold to life-threading epidemics like SARS, and MERS. What is COVID-19? COVID-19 is a novel infection caused by novel Coronavirus now termed as...Find More
Amid the breakout in Wuhan, China, the novel coronavirus has managed to invade the other countries across the globe. Till now, almost 25 countries including several Asian, northern American, Australia and European countries, have reported confirmed cases of coronavirus. With the infected cases totalling to 4...Find More
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.